Probst, A; Dang, T; Bochud, M; Egger, M; Negro, F; Bochud, P-Y (2011). Role of hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis. Journal of viral hepatitis, 18(11), pp. 745-759. Oxford: Blackwell Science 10.1111/j.1365-2893.2011.01481.x
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Probst JViralHepatitis 2011.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (190kB) |
The progression of liver fibrosis in chronic hepatitis C has long been considered to be independent from viral genotypes. However, recent studies suggest an association between Hepatitis C virus (HCV) genotype 3 and accelerated liver disease progression. We completed a systematic review and meta-analysis of studies evaluating the association between HCV genotypes and fibrosis progression. PubMed, Embase and ISI Web of Knowledge databases were searched for cohort, cross-sectional and case-control studies on treatment-naïve HCV-infected adults in which liver fibrosis progression rate (FPR) was assessed by the ratio of fibrosis stage in one single biopsy to the duration of infection (single-biopsy studies) or from the change in fibrosis stage between two biopsies (paired biopsies studies). A random effect model was used to derive FPR among different HCV genotypes. Eight single-biopsy studies (3182 patients, mean/median duration of infection ranging from 9 to 21 years) and eight paired biopsies studies (mean interval between biopsies 2-12 years) met the selection criteria. The odds ratio for the association of genotype 3 with accelerated fibrosis progression was 1.52 (95% CI 1.12-2.07, P = 0.007) in single-biopsy studies and 1.37 (95% CI 0.87-2.17, P = 0.17) in paired biopsy studies. In conclusion, viral genotype 3 was associated with faster fibrosis progression in single-biopsy studies. This observation may have important consequences on the clinical management of genotype 3-infected patients. The association was not significant in paired biopsies studies, although the latter may be limited by important indication bias, short observation time and small sample size.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) |
UniBE Contributor: |
Egger, Matthias |
ISSN: |
1352-0504 |
Publisher: |
Blackwell Science |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:21 |
Last Modified: |
05 Dec 2022 14:06 |
Publisher DOI: |
10.1111/j.1365-2893.2011.01481.x |
PubMed ID: |
21992794 |
Web of Science ID: |
000296464900001 |
BORIS DOI: |
10.7892/boris.7303 |
URI: |
https://boris.unibe.ch/id/eprint/7303 (FactScience: 212501) |
Actions (login required)
 |
Edit item |